Search results
Results from the WOW.Com Content Network
AMP organizes educational webinars throughout the year as well as review courses and certificate programs for individuals seeking in-depth knowledge of molecular topics. [2] AMP also outreaches to patients with an education webpage, Molecular Medicine for Patients, [7] focused on molecular testing and its impact on human health. These ...
The American Board of Clinical Chemistry (ABCC) is an American doctoral board certification agency for clinical chemistry, toxicological chemistry, and molecular diagnostics. It was founded in 1950 with sponsorship from the American Chemical Society (ACS), American Institute of Chemists (AIC), and the American Society of Biological Chemists. [1]
The ASCP Board of Registry (BOR) was established in 1928 as the "Registration Bureau for Technicians" as the first certification agency for clinical laboratory personnel in the US. [ 9 ] [ 10 ] ASCP was the first professional medical organization to set standards for laboratory professionals, which initially only required a recommendation from ...
NAACLS is the primary accrediting body for clinical laboratory programs in the US, though the Accrediting Bureau of Health Education Schools(ABHES) also accredits a handful of programs. [1] Graduates of the ABHES are not eligible for the American Society for Clinical Pathology (ASCP) certification, but are eligible for the American Medical ...
The American Medical Technologists (AMT) is a professional association that encompasses 80,000 allied health professionals. It was founded in 1939. [1] [2]The organization published a bi-monthly journal entitled The Journal of American Medical Technologists. [3]
A Medical Laboratory Scientist (MLS) or Clinical Laboratory Scientist (CLS) or Medical Technologist (MT) is a licensed Healthcare professional who performs diagnostic testing of body fluids, blood and other body tissue. The Medical Technologist is tasked with releasing the patient results to aid in further treatment.
Molecular diagnostics uses in vitro biological assays such as PCR-ELISA or Fluorescence in situ hybridization. [19] [20] The assay detects a molecule, often in low concentrations, that is a marker of disease or risk in a sample taken from a patient.
The number of notable protein-ligand docking programs currently available is high and has been steadily increasing over the last decades. The following list presents an overview of the most common notable programs, listed alphabetically, with indication of the corresponding year of publication, involved organisation or institution, short description, availability of a webservice and the license.